Diabetes treatment is constantly evolving, with new therapeutic options developing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions https://lucvgle223499.is-blog.com/45877234/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment